Enveric Biosciences (ENVB) Shares Outstanding (Entity) (2010 - 2026)
Enveric Biosciences (ENVB) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | 575.47 Mn |
| 10 | Enveric Biosciences | 5.50 Mn | -2.79 Mn | - | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 334,719.00 |
| Sep 30, 2025 | 313,242.00 |
| Jun 30, 2025 | 252,159.00 |
| Mar 31, 2025 | 149,809.00 |
| Dec 31, 2024 | 41,907.00 |
| Sep 30, 2024 | 49,972.00 |
| Jun 30, 2024 | 43,770.00 |
| Mar 31, 2024 | 22,231.00 |
| Dec 31, 2023 | 11,995.00 |
| Sep 30, 2023 | 12,122.00 |
| Jun 30, 2023 | 11,899.00 |
| Mar 31, 2023 | 11,546.00 |
| Dec 31, 2022 | 8,033.00 |
| Sep 30, 2022 | 11,546.00 |
| Jun 30, 2022 | 5,856.00 |
| Mar 31, 2022 | 4,706.00 |
| Dec 31, 2021 | 2,624.00 |
| Sep 30, 2021 | 2,571.00 |
| Jun 30, 2021 | 2,383.00 |